Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy". Issue 12 (December 2020) - Koemans, W.J.; van Sandick, J.W.; Huitema, A.D.R.